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ABSTRACT
The utility of previously generated microarray data is
severely limited owing to small study size, leading to
under-powered analysis, and failure of replication.
Multiplicity of platforms and various sources of
systematic noise limit the ability to compile existing
data from similar studies. We present a model for
transformation of data across different generations
of Affymetrix arrays, developed using previously
published datasets describing technical replicates
performed with two generations of arrays. The
transformation is based upon a probe set-specific
regression model, generated from replicate measure-
ments across platforms, performed using correlation
coefficients. The model, when applied to the expres-
sion intensities of 5069 shared, sequence-matched
probe sets in three different generations of
Affymetrix Human oligonucleotide arrays, showed
significant improvement in inter generation correla-
tions between sample-wide means and individual
probe set pairs. The approach was further validated
by an observed reduction in Euclidean distance
between signal intensities across generations for
the predicted values. Finally, application of the
model to independent, but related datasets resulted
in improved clustering of samples based upon their
biological, as opposed to technical, attributes. Our
results suggest that this transformation method is a
valuabletoolforintegratingmicroarraydatasetsfrom
different generations of arrays.
INTRODUCTION
Microarrays have been widely used as exploratory tools for
genome-wide analysis of gene expression and allow for
simultaneous comparison of thousands of transcripts for
detectable expression proﬁle changes. The application of
microarrays has not been limited only to differential gene
expression studies. They have been used for gene detection,
disease diagnosis, pharmaco- and toxicogenomics. Among
the different formats of microarrays, those containing short
oligonucleotides synthesized in situ using photolithography,
developed by Affymetrix, have become the most common
method of analysis. Affymetrix GeneChip arrays use sets of
25mer oligos as probes, with each set of probes (probe set)
representing a gene/transcript. Expression measurements for
sets of probes from individual probe sets are summarized,
giving an estimate of the expression of the gene represented
by the probe set. With continuing updates of mammalian gen-
ome sequence, oligonucleotide probe sequences are periodic-
ally changed in order to account for sequence accuracy and
uniqueness (1,2). This requires the development of new gen-
erations of microarrays.
Gene Expression Omnibus (GEO) (3), a database curated
and maintained by the National Institutes of Health (NIH),
currently has an abundance of data for two versions of Affy-
metrixHumanGenome(HG)chips;HG-U95Av2(66datasets)
and HG-U133A (55 datasets). The HG-U95Av2 array repres-
ents  10000 full-length genes based on UniGene database
(Build 95) and associated annotations. The HG-U133A 2.0
array represents 14500 well-characterized human genes.
Sequences used in the design of the array were selected
from GenBank
 , dbEST and RefSeq. The sequence clusters
were created from the UniGene database (Build 133, April 20,
2001) and then were reﬁned by analysis and comparison with a
number of other publicly available databases including the
Washington University EST trace repository and the Univer-
sity of California, Santa Cruz Golden-Path human genome
database (April 2001 release) (Affymetrix Product Support,
2004). Additionally, a substantial number of microarray stud-
ies were performed using the Affymetrix HuGeneFL (aka HG-
U6800) chip. This array, initially released by Affymetrix in
November 1998, enables the relative monitoring of mRNA
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doi:10.1093/nar/gni159transcripts of  5600 full-length human genes selected from
UniGene Build 18 supplemented with additional genes from
GenBank and TIGR.
Even with the latest advancements in microarray techno-
logy, the calculated gene expression value contains a substan-
tial amount of noise and heteroscedascity, in part owing to the
large number of observations and the wide range of gene
expression values (4). Different empirical strategies devised
for noise reduction include establishing a variable threshold
for fold-changes (5), noise-ﬁltering look up tables (6), non-
parametric bootstrap for identiﬁcation and correction for
potential confounding effects (7) and other normalization
techniques (8), as well as using technical and biological rep-
licates to estimate the variability in gene expression (9).
Application of fold-change thresholding has been by far the
most commonly applied method of noise reduction. Technical
variability, being smaller in comparison with biological vari-
ability, can be overcome by using adequate sample size, with
large numbers of replicates (10,11).
Combining results from different studies and/or arrays has
been difﬁcult owing to an absence of standardized protocols
for background correction, normalization and calculation of
expression values. Meta-analysis approaches have been
applied to microarray data in order to combine results from
different labs, in the absence raw data from which the results
have been derived. In certain cases, these approaches have
proven very successful (12–14). However, when applied to
microarray data, meta-analysis is complicated by additional
statistical (e.g. multiple comparisons) and non-statistical
issues (e.g. probe annotation). Some attempts have combined
P-values across platforms (14–16), but such approaches can
limit the capture of response magnitude (14) or biological
signiﬁcance (17). Unfortunately, most microarray studies suf-
fer from lack of sufﬁcient sample size. Datasets with sufﬁcient
numbers of controls and replicates are rarely generated under a
proper experimental design, in order to make appropriate com-
parisons. Insufﬁcient sample size limits biological insight and
contributes to poor reproducibility across sample populations.
There may even be substantial variation in the measured
intensity levels for the same gene within the same generation
of chips and for replicates of single tissue samples (6). Fur-
thermore, unprocessed data ﬁles (e.g. CEL and .DAT ﬁles) are
largely unavailable. Finally, the existence of differences
among the many different technologies also makes it hard
to combine the data. For instance, some studies have reported
cross-platform comparisons and found varying degrees of
agreement, ranging from the G–C content, sequence overlap
and average signal intensity (2,18,19). Compiling previously
published microarray datasets, from studies with similar
experimental conditions and study design, can be an efﬁcient
way of improving the reliability of results and provide appro-
priate statistical power. Moreover, as the number of publicly
available datasets in public data depositories [e.g. GEO (3);
Stanford Microarray Database (20); and ArrayExpress at EBI
(21)] grows, it is clear that these datasets should be
combined to generate a more comprehensive understanding
of underlying biology.
Two previous studies have performed comparisons across
generations of Affymetrix arrays. A comparison of HuGeneFL
(aka HG-U6800) and HG-U95Av2 arrays concluded that the
reproducibility is high when the two probe sets share many
exact probes and that it is low when they do not (22). Another
comparison of HG-U95A and HG-U133A arrays concluded
that data from different generations of microarrays can be
combined by ﬁltering the probes based on their sequence over-
laps (23). The beneﬁts of probe sequence matching upon
measurement precision extend across multiple microarray
platforms and technologies (1,2).
In the current study, we propose a method for utilizing
available datasets by combining signals derived from different
generations of Affymetrix arrays. We developed the methodo-
logy using the two previously described intergeneration com-
parisons of Affymetrix Human arrays (http://www.chip.org/
~ashish/Reproducibility and http://www.ncbi.nlm.nih.gov/
projects/geo/query/acc.cgi?acc=GSE2044) (22,23). First, we
identiﬁed probe sets that have signiﬁcant sequence overlap
between three generations of Affymetrix human arrays
(HuGeneFL, HG-U95Av2 and HG-U133A). Next, we derived
regression models foreach ofthe sequence-matched probe sets
based on the pairwise correlations from replicate measure-
ments. Finally, we developed an algorithm for transformation
of expression intensities obtained from one generation of
arrays to another. These predicted values resulted in a signi-
ﬁcant improvement in correlations and reduction in Euclidian
distance in replicate measurements across generations. We
suggest this regression-based approach be taken for inter-
generation conversion of signal intensities and recommend
that this strategy be limited to genes represented by
sequence-matched probe sets.
METHODS
Microarray data
Data ﬁles were obtained from four previous studies: Hwang
et al. (23) compared expression in 14 human inﬂammatory
myopathy samples. Total RNA was extracted and a portion
was hybridized to HG-U95Av2 arrays while the remaining
RNA was frozen and then later hybridized to HG-U133A
arrays at the same core facility. Nimgaonkar et al. (22) com-
pared expression in seven humanmuscle samples concurrently
hybridized to HuGeneFL and HG-U95Av2 chips. Beer et al.
(24) analyzed gene expression in 104 human lung tissue sam-
ples, including 87 adenocarcinomas and 17 normal lungs,
hybridized to HuGeneFL arrays. Bhattacharjee et al. (25) ana-
lyzed gene expression in 203 human lung tissue samples
including adenocarcinomas (n ¼ 127), squamous cell carcino-
mas (n ¼ 21), pulmonary carcinoids (n ¼ 20), small cell lung
cancer (n ¼ 6) and normal tissue (n ¼ 17) specimens using
the HG-U95Av2. We limited our analysis of the Bhattacharjee
et al. (25) dataset to the adenocarcinomas and normal lung
samples which are comparable in sample with those used by
Beer et al. (24). The raw image ﬁles were obtained and pro-
cessed using MAS 5.0 and the non-normalized, background
subtracted signal intensities were extracted.
Probe set matching
The annotation information for each probe set in HuGeneFL,
HG-U95Av2 and HG-U133A arrays was retrieved from
NetAffx Analysis Center (26). According to the annotation
information, HuGeneFL has 7129 probe sets annotated from
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probe sets, annotated by 9091 UniGene and 8672 LocusLink
identiﬁers. The U133A array is composed of 22283 probe
sets annotated by 13624 UniGene and 12769 LocusLink
identiﬁers.
We limited our analysis to those probe sets with the greatest
likelihood of representing the same gene across generations
by implementing the Affymetrix ‘Best Match’ algorithm. For
sequence comparisons, the best match from the HG-U95Av2
to the HuGeneFL, represents instances where the probability
of the two sequences match randomly (P-value < e
 40)o r
percent overlap is >90% over at least 70 bases. Additionally,
probe sets were matched if they were identical across the
platforms (Affymetrix provides a list of the numbers of
probe pairs common for the two generations) (http://www.
affymetrix.com/analysis/index.affx).
For comparison of HG-U95Av2 and HG-U133A, Affymet-
rix provides the probe set matches for comparative analysis.
These matching tables were constructed based on the sequence
information of probe sets as follows: to begin with, all possible
probe set pairs between two generations were checked by their
similarity in the representative sequence for selection. Then,
among these matching probe set pairs, some were selected as
‘Good Match’ pairs based on three criteria: (i) if the percent
identity between the representative sequences was >90%, (ii)
the length of the representative sequence was >100 bp and (iii)
at least one perfect match probe of one array generation was
perfectly aligned to the probe selection region of the other
array generation. Further, a ‘Best Match’ subset was selected
by more stringent criteria on the similarity of probe set pairs.
Finally, an overlap of the best match probe sets of both
comparisons was obtained. Subsequent use of the term
‘Best Match’ represents this subset of matching probe sets.
Correlation coefficients
The correlation coefﬁcient was used as a metric of congruency
of measurement between matched probe sets across the two
generations of Affymetrix arrays. First, the signal intensity
data were normalized to a mean of 0 and SD of 1. To assess
the cross-generation correlation of gene-expression measure-
ments we computed both the Pearson linear correlation coef-
ﬁcients and Spearman rank-order correlation coefﬁcients for
best match probe sets for each array pair. In addition, the
expression measure of a probe set for a given platform was
computed as the mean of the all the samples for a given array.
Regression model
In order to develop a model for transformation of expression
intensities, a linear regression model was developed. For each
of the probe sets, as well as for the sample wide means, the
expression intensities of replicate (same sample) hybrid-
izations on different generations of arrays was modeled.
A representative equation for the linear regression model
for a particular probe set can be written as
aiXij þ bi ¼ Yij 1
where Xij ¼ expression intensity of probe set i for sample j in
array 1, Yij ¼ expression intensity of the same probe set in the
same sample in array 2, a ¼ slope and b ¼ intercept (for one
dataset). The regression models developed were used to
generate a modiﬁed regression model that would predict the
expression intensities of array 2 using the intensities in array 1
based on the expression intensities from one dataset. This
process was repeated for the second dataset. Further we
also developed two more regression models, one for each
of the two datasets. In this case X represented the sample-
wide mean expression intensity of all probe sets in array 1
and Y is the sample-wide mean expression intensity of the all
probe sets in array 2, a ¼ slope and b ¼ intercept.
We have developed a model based on the linear regression
of sample-wide means of expression intensities from different
generations of arrays along with the regression model for the
expression intensities of all the probe sets across two genera-
tions. First we generated a model for sample-wide means for
all best match probe sets for HG-U95Av2 and HG-U133A
arrays from the Hwang et al. (23) dataset
Y ¼ a0X þ b0 2
where Y represents the outcome variable, which in this case is
the sample-wide mean for all 5069 best match probe sets in
HG-U95Av2 array while X represents the predictor variable
which is the sample-wide mean for the same probe sets in HG-
U133A array. a0 and b0 represent the slope and intercept,
respectively, for the model.
We also generated a set of models, one representing each of
the 5069 best match probe sets from the Hwang et al. (23)
dataset
Ynm ¼ anXnm þ bn n ¼ 1‚2‚ ...‚5069; m ¼ 1‚14 ðÞ 3
where Ynm represents the expression intensity for each of
individual probe sets in samples 1–14 hybridized to HG-
U95Av2 arrays while Xnm is the expression intensity for the
same probe sets for samples (1–14) hybridized to HG-U133A
array. an and bn represent the slopes and intercepts, respect-
ively, for each model. This procedure provided us with 5069
individual regression models one for each of the best match
probe sets.
Next we developed a model for sample-wide means for the
5069 best match probe sets in HG-U95Av2 and HuGeneFL
arrays from the Nimgaonkar et al. (22) dataset
Y ¼ c0X þ d0 4
where Y represents the outcome variable, which in this case is
the sample-wide mean for all 5069 best match probe sets in
HuGeneFL array while X represents the predictor variable
which is the sample-wide mean for the same probe sets in
HG-U95Av2 array. c0 and d0 represent the slope and intercept,
respectively, for the model.
We also generated a set of models, one representing each of
the 5069 best match probe sets from Nimgaonkar et al. (22)
dataset
Ynm ¼ cnXnm þ dn n ¼ 1‚2‚ ...‚5069; m ¼ 1‚ ...‚7 ðÞ 5
where Ynm represents the expression intensity for each of indi-
vidual probe sets in samples 1–7 hybridized to HuGeneFL
arrays while Xnm is expression intensity for the same probe
sets for samples (1–7) hybridized to HG-U95Av2 array. cn and
dn represent the slopes and intercepts, respectively, for each
model. This procedure provided us with 5069 individual
regression models one each of the best match probe sets.
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wide means (overall) model as additive correctional factors
in developing our inter-generational transformation model
for the individual probe sets. The model for converting
HG-U95Av2 values to HG-U133A values [based on
Hwang et al. (23) data] for each probe set can be
represented as
Y
0
nm ¼ an þ a0 ðÞ Xnm
þ bn þ b0 ðÞ ð n ¼ 1‚2‚ ...‚5069; m ¼ 1‚14Þ 6
where Y
0
nm is the predicted value for HG-U133A expression
intensities for each of the 5069 best match probe sets, while
Xnm represents the expression intensity for the same probe sets
for samples HG-U95Av2 array. The slope in the model is
represented by sum of a0 and an, where a0 serves as a correc-
tion factor while intercept is the sum of b0 and bn with b0
serving as the correction factor in this case.
In the same fashion, we derived the model for transforma-
tion from HuGeneFL to HG-U95Av2 [based on Nimgaonkar
et al. (22)]
Y
0
nm ¼ cn þ c0 ðÞ Xnm
þ dn þ d0 ðÞ ð n ¼ 1‚2‚ ...‚5069; m ¼ 1‚7Þ 7
where Y
0
nm is the predicted value for HG-U95Av2 expression
intensities of individual probe sets, while Xnm represents
the expression intensity for the probe sets for samples HuGen-
eFL array. The slope in the model is represented by sum of
c0 and cn, while intercept is the sum of d0 and dn. In absence
of a dataset, we could not develop a model for direct trans-
formation of HuGeneFL signal intensities to HG-U133A
values.
For the sake of maintaining uniformity we present a uni-
versal equation for all inter-generational transformation
among Affymetrix arrays that can be represented as
ai þ ao ðÞ Xij þ bi þ bo ðÞ ¼ Yij 8
where Xij is the expression intensity of probe set i for sample j
in array available while Yij is the expression intensity of the
same probe set in the same sample in array to which the values
have to be converted to, ai is probe set slope and ao is the
correction factor,while biisthe intercept forthe probe setsand
b0 is the correction factor.
Hierarchical clustering
Average linkage agglomerative hierarchical clustering based
upon Euclidean distance was implemented using the Gene
Expression Data Analyzer (27).
RESULTS
We identiﬁed 6375 probe sets among the matching probe set
pairs between HuGeneFL and HG-U95Av2, which met all the
criteria for best match between the two arrays. Similarly, we
identiﬁed 10508 probe sets (representing 9000 unique genes)
among the overlapping probe set pairs between HG-U95Av2
and HG-U133A, which met all the criteria for best match
between the two arrays. We further identiﬁed overlaps
among the above two best match sets and focused our analysis
on only these 5069 probe sets (Figure 1).
To assess the similarity among different generations of
arrays, we examined the correlation of standardized expres-
sion intensities of replicate measurements, obtained using the
Affymetrix MAS 5.0 algorithm. The correlation coefﬁcient
Figure 1. A schematic outline of the procedure. Sequence-matching identified 5069 ‘best match’ probe sets shared across three generations of human microarrays.
The expression intensities of those 5069 probe sets from the two datasets were used to compute correlation coefficients. Regression models were generated using
expression values of paired probe sets and the sample-wide mean expression intensities. Final models for transformation were developed by applying correction
factors to the above regression models. ‘Transformed’ expression measures were calculated for the 5069 probe sets. In the above regression equations, a and c
represent the slopes while b and d represent the intercepts for the two models.
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HuGeneFL and HG-U95Av2 was 0.82 with a range from
0.9946 to  0.1357 for each of the individual probe sets.
Between HG-U95Av2 and HG-U133 the correlation coefﬁ-
cient was 0.87 with a range of 0.9921 to  0.115 for individual
probe sets. After modeling and transformation, correlation
values increased signiﬁcantly when calculated using the pre-
dicted expression intensity measurements (Figure 2). We
observed a correlation of 0.942 between the sample-wide
means of the actual HG-U95Av2 and the transformed
HuGeneFL intensity values predicted using our regression
model. When compared with the sample-wide means of actual
HuGeneFL signal intensities, the predicted HuGeneFL values
had a correlation of 0.9457. The pairwise correlations for
individual probe sets between HG-U95Av2 and the predicted
HuGeneFL in most of the cases increased to 1. Similarly, the
correlation between sample-wide means of actual HG-U133A
and HG-U95Av2 values predicted using our regression model
improved to 0.96. The pairwise correlations for individual
probe sets between HG-U133A and the predicted values
of HG-U95Av2 also increased to 1 in most cases. For both
datasets, in some cases the correlation for individual probe
sets in the transformed data was  1, owing to a negative
correlation prior to transformation. This was limited to a
small number of probe sets [ 3.6% in Nimgaonkar et al.
(22), and  12% in Hwang et al. (23)]. The sample-wide
means correlation between actual and predicted HuGeneFL
was 0.962 and between the actual and predicted values of HG-
U95Av2 was 0.973.Theoverallsample-wide meancorrelation
was improved after transformation, in the HuGeneFL to
U95Av2 and the U95Av2 to U133A comparisons. Spearman
rank correlations calculated for individual probe sets were
also increased (data not shown), but the data were of limited
power owing to low sample sizes of 7 and 14 in the two
comparisons.
To further assess the improvements in the transformed data,
we calculated the distances in Euclidean space among the
probe set pairs between actual and predicted values. The Euc-
lidean distance between actual expression intensity values for
probe sets between HuGeneFL and HG-U95Av2 had a mean
of 0.82 U (range from 0.0915 to 22 U) prior to transformation,
and a mean of 0.79 (range from 0.077 to 22 U) after trans-
formation (Figure 3a). Similarly, the distance between actual
signal values between HG-U95Av2 and HG-U133A had a
mean of 1.49 (range from 0.0095 to 42) before transformation,
and a mean of 1.06 (range from 0.0047 to 29) after
Figure 2. Transformation improves probe set level correlations. A histogram displaying the correlation in expression intensity across two platforms for each
sequencematchedprobesetrankedindescendingorder.Thecorrelationofindividualprobesetsforbothdatasets(a)Nimgaonkaretal.(22)and(b)Hwangetal.(23)
show significant increase after modeling and transformation of the expression intensities.
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Euclidean distance was signiﬁcantly improved after trans-
formation, with a P-value < 0.001 in both the HuGeneFL to
U95Av2 and the U95Av2 to U133A comparison.
Next, in order to further deﬁne the success of our model to
transform data from one array platform to another, we imple-
mented average linkage hierarchical clustering of the datasets
using the 5069 best match probe sets (Figure 4). Clustering of
pre-transformation datasets resulted in complete separation of
the samples based entirely upon the platform on which the data
was generated (Figure 4a and c). We applied our transforma-
tion procedure tothe data and repeatedthe clustering, resulting
in partial, but incomplete, mixing of samples from different
generation ofarrays.The absenceof completeclustering based
upon sample type in the transformed data was possibly owing
to residual noise in the datasets. Therefore, we took a standard
approach for noise reduction of trimming (thresholding) the
transformed dataset and repeated the clustering procedure.
For the HuGeneFL to HG-U95Av2 dataset, clustering of
2020 probe sets with a minimum correlation coefﬁcient
of r ¼ 0.80, resulted in complete separation of samples
dependent upon sample type, and independent of platform
(Figure 4b). Similar results were found for the HG-U95Av2
and HG-U133A dataset, when clustering 1263 probe sets with
a minimum r ¼ 0.74 (Figure 4d). For hierarchical clustering,
we are using Euclidean distance, and not the correlation, as
post scaling squared Euclidean distance is equivalent to cor-
relation distance (28). It has been shown in the past that Euc-
lidean distance performed better than Pearson’s correlation
coefﬁcient when it comes to the clustering of samples (29).
Clearly, our method of sequence-matching and linear
regression modeling of microarray data can transform replic-
ate samples run on multiple platforms. In an effort to deter-
mine how our model would function on archived datasets
describing related, but independent biological samples, we
applied the transformation procedure to two independent data-
sets (24,25) containing data from human lung specimens. We
separated normal tissue samples from tumor samples in order
to better test the ability of the transformation procedure to
relate biologically similar samples. We merged the MAS
5.0 expression intensities generated de novo from the
raw data (.CEL) ﬁles from both datasets, and performed
Figure 3. Transformation increases similarity in expression measure for sequence-matched probe sets. A line diagram displaying the Euclidean distance between
signalintensitymeasurementsformatchedprobesetsacrossthetwoplatforms,rankedindescendingorder.TheEuclideandistancesofindividualprobesetsforboth
datasets (a) Nimgaonkar et al. (22) and (b) Hwang et al. (23) show a significant decrease after modeling and transformation of expression intensities.
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tion, the signal intensities from the 5069 genes showed a
sample-wide mean correlation of 0.78 for normal lung tissue
samples and 0.82 for adenocarcinoma samples. As expected,
the samples formed clusters based entirely upon the array
generation. Next, we applied our transformation procedure
to convert the signal values from the HuGeneFL dataset
(24) to their corresponding HG-U95Av2 values (25). Post-
transformation signal intensities showed a sample-wide
mean correlation of 0.82 for normal lung tissue samples
and 0.94 for adenocarcinoma samples. For the normal sam-
ples, clustering of 745 probe sets with minimum correlation
coefﬁcient of r ¼ 0.40, resulted in platform-independent clus-
tering of samples (Figure 5b). Similar platform-independent
sample mixing was observed for adenocarcinoma samples
when clustering 584 probe sets with a minimum r ¼ 0.11
(Figure 5d).
DISCUSSION
With an increasing number of microarray datasets being
deposited in the public domain, real opportunity exists for
more reliable information to be generated through the integ-
ration of multiple, independently generated datasets focusing
on the same biological paradigm. This possibility is hindered
by the fact that there is large amount of technical variability
associated with microarray data. This is due to a number of
factors including, but not limited to, differences in technical
platforms, differences in data processing methods and probes
sequence errors. Methods that can overcome these problems
and allow compilation of diverse datasets will have a profound
impact upon the future of this technology.
In this study we aimed to develop a model for transforming
expression intensity values obtained from one generation
of Affymetrix oligonucleotide array to another. We used
three generations of human arrays HuGeneFL, HG-U95Av2
and HG-U133A. Even though all three arrays belonged to the
same technological platform type (short oligonucleotide
array), there were signiﬁcant differences among the three
generations; such as different sources of probe selection
regions (UniGene Builds 18, 95 and 133 for HuGeneFL,
U95Av2 and U133A, respectively), different numbers of
probe pairs per probe set (20, 16 and 11 in HuGeneFL,
U95Av2 and U133A, respectively), and different probe selec-
tion methods (30).
Recently, many studies have highlighted the beneﬁt of
probe sequence matching in improving the consistency of
data from the same biological paradigm generated from mul-
tiple microarray platforms. For cross-platform comparison
studies, matching of UniGene IDs is the most common method
used. However, with each update of the UniGene database,
few oldtags are removed andnew tags are added, andtheseare
hard to track correctly unless the same build of UniGene was
used to annotate each platform. Using LocusLink IDs for
Figure 4. Transformation results in sample-related, instead of platform-related clustering. Average linkage hierarchical clustering was performed on the data from
Nimgaonkar et al. (22) (a and b) and Hwang et al. (23) (c and d) before (a and c) and after (b and d) data transformation. The datasets cluster dependent upon the
platform used prior to transformation, but cluster dependent upon the biological sample after transformation.
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we showed a large statistical beneﬁt in measurement precision
within and across platforms by limiting analysis to data gen-
erated from sequence validated or sequence-matched probes
(1,2).Another previous study (23) comparedthree methods for
matching probe sets between two generations of arrays;
UniGene IDs and LocusLink IDs, and best match probe
sets provided by Affymetrix (Methods). This study concluded
that UniGene and LocusLink matching gave similar results,
but best match provided higher reproducibility than other
matching methods. We therefore used the ‘Best Match’
algorithm, as outlined in Methods section above, as the criteria
for the selection of matching probe sets. These criteria yielded
a set of 5069 probe sets that were common in HuGeneFL,
HG-U95Av2 and HG-U133A (Figure 1).
Nimgaonkar et al. (22) compared the correlations of expres-
sion intensities across two generations of the Affymetrix
arrays, HuGeneFL and HG-U95Av2. They reported 2200
(27%) of 8044 matched probe sets had negative correlations,
i.e. the gene expressionpatternschangedinoppositedirections
between the two generations (22). We found the number of
probe sets showing negative correlations was considerably
reduced using the Best Match criteria (181 probe sets in
5070 common probe sets,  3.6%). Therefore, sequence-
matching using the Best Match criteria (or other sequence
matching method) during data preprocessing is an important
step for combinatorial analysis in order to reduce the technical
variance between platforms. Obviously, limiting the datasets
by sequence matching results in the loss of some potentially
signiﬁcant information. For example, only  50% of the probe
Figure 5. Transformationresultsinplatform-independentclusteringofarchiveddatasetsdescribinghumanlungcancer.Averagelinkagehierarchicalclusteringwas
performed on the human lung tissue data from Beer et al. (24) and Bhattacharjee et al. (25). Samples from normal lung tissue (a and b) and adenocarcinoma
tissue(candd)wereanalyzedbefore(aandc)andafter(bandd)datatransformation.Thedatasetsclusterdependentupontheplatformusedpriortotransformation,
but cluster dependent upon the biological sample type after transformation.
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used in the analysis. This limitation is unavoidable in order
to retain the highest level of conﬁdence in the data derived
from combining datasets from different arrays. However, the
limitation must be contrasted with the advantage of being able
to both combine datasets with different generation of arrays
and retain the highest levelofconﬁdence inthe results derived.
Affymetrix microarray technology consistently shows high
technical reproducibility, typically in the range of >0.90 (31).
The mean correlation in expression for the 5069 best match
probe sets were 0.82 and 0.87 when comparing data generated
using different generations of arrays, much lower than that
reported in past studies for technical replicates using one plat-
form.Thisdifferenceincorrelationcoefﬁcients isameasureof
the loss of precision when integrating datasets across genera-
tions of the same platform. In a previous study involving two
different generations of Affymetrix Arabidopsis arrays, the
average inter-generation correlation was reported to be 0.81
(32), very similar to our observations. However, this value can
be considerably improved by the modeling procedure we
describe. Our sequence matching and data modeling methods
transformed a vast majority [96% in Nimgaonkar et al. (22)
and 88% in Hwang et al. (23)] of the correlations for sequence
matched probe sets to 1, and also produced a signiﬁcant
decrease in Euclidean distance between signal intensities
for corresponding probe sets, indicating the success of the
procedure.
The transformation procedure we describe here clearly does
not remove all components of variation or noise from the
dataset. This is observed in the inability to generate ideal
clustering (evidenced by mixing of samples from different
platforms) using data from all 5069 probe sets, even after
transformation. Improved mixing was observed after trimming
the datasetsinan effort toremove residualnoise. One rationale
for the remaining noise, even following transformation, is that
our model affects the scale, but not the distribution of the
datasets. It is commonly observed that expression intensities
derived from different arrays of the same platform are scaled
and distributed differently (22,23,33). Jiang et al. (33) further
showed that even after normalization, the scales and distribu-
tions of the two datasets remained different. This is attributed
to the difference in the hybridization signal intensities between
two platforms. In our analysis HuGeneFL had highest overall
intensity and lowest variance in comparison with HG-U95Av2
and HG-U133A. These differences may be due to either vari-
ations in photo-multiplier tube settings used for data acquisi-
tion associated with different arrays, or to differences in probe
numbers and the sequences for each gene. As a result, data
distributions varied greatly between the pre- and post-
transformation versions of the dataset.
Pre-transformation clustering of the replicate datasets res-
ulted in separation of samples according to the platform, while
post-transformation clustering resulted in separation accord-
ing to sample type. Of greatest importance, we observed sim-
ilar results with independent human lung datasets, where
samples were not replicates, but biologically related. This
sample type-dependent clustering was improved after remov-
ing (thresholding) data from probe sets providing low-quality
signals, as determined by the low correlations in expression
across the datasets. The success achieved in clustering non-
replicate samples from two independent sources validates this
model as a unique and rational method for integration of
microarray data across platforms.
One of the primary concerns of using linear regression
models to generate expression intensities has been that
although these models scale the values, they provide no
added beneﬁt to analyses of differential expression. Although
microarray data can be used formany purposes, such aspatient
classiﬁcation (class discovery and class prediction), a major
application of the data is to deﬁne differential expression. As
previously stated, the method described here is most suited to
datasets of limited size and statisticalpower, which describes a
vast majority ofthoseavailable. In suchcases, meta-analysisis
of limited value owing to the low level of reliability of the
individual datasets combined with the concerns of translating
gene expression measurements and probe annotation across
platforms. Data compilation improves the statistical power of
small datasets by increasing the number of observations. The
sequence matching and regression modeling approach
described here overcomes these problems and allows for
the reliable compilation of data from independent platforms.
Furthermore, initial results (S. Bhattacharya and T. J. Mariani,
unpublished data) indicate that this method leads to increased
sensitivity, speciﬁcity and reliability when deﬁning
differential expression.
CONCLUSION
We have developed an approach for inter-generational trans-
formation of gene expression microarray signal intensity val-
ues. This method relies upon; (i) sequence matching of probes
across platforms to ensure measurement of the same biological
variable, and (ii) linear regression modeling of data derived
from technical replicates performed on more than one plat-
form. Our results suggest that success in modeling gene
expression microarray data across platforms is achievable.
Continuing efforts should lead to dramatic improvements in
inter-generation transformation of microarray data.
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